today's wacc — Diagnostics & Lab Equipmentⓘ

9.49%

+ new wacc

all›Healthcare›Medical Devices›Diagnostics & Lab Equipment

Hangzhou Tigermed Consulting11.94%

Joinn Laboratories(China)Co.,Ltd11.64%

Metropolis Healthcare11.15%

Guardant Health10.98%

OPKO Health10.68%

Illumina10.61%

Dian Diagnostics Group10.54%

Guangzhou Kingmed Diagnostics Group10.37%

WuXi AppTec9.90%

Medpace Holdings9.82%

Agilent Technologies9.82%

Waters9.68%

Mettler-Toledo International9.58%

Lonza Group9.53%

Sotera Health9.43%

Castle Biosciences9.37%

RadNet9.31%

Charles River Laboratories International9.28%

Dr. Lal PathLabs8.98%

ICON Public8.67%

Revvity8.62%

Vijaya Diagnostic Centre8.44%

NeoGenomics8.27%

Danaher8.17%

Thermo Fisher Scientific8.15%

IQVIA Holdings8.10%

Qiagen7.89%

Sonic Healthcare7.52%

Fleury7.48%

Eurofins Scientific7.38%

Shanghai Runda Medical Technology7.24%

Quest Diagnostics7.09%

H.U. Group Holdings6.29%

methodology

WACC is calculated as the weighted average of the cost of equity and the after-tax cost of debt, using median unlevered betas (5-year monthly, adjusted via Blume) relevered with median net-debt capital structures via the Hamada equation.

Cost of equity = risk-free rate + relevered beta × equity risk premium. Cost of debt = (risk-free rate + credit spread) × (1 − tax rate).

Data is updated daily. Read our full methodology on the sources page.